Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans.
about
beta3-adrenoceptor agonist prevents alterations of muscle diacylglycerol and adipose tissue phospholipids induced by a cafeteria dietBedside-to-Bench Translational Research for Chronic Heart Failure: Creating an Agenda for Clients Who Do Not Meet Trial Enrollment CriteriaCombination of a Beta adrenoceptor modulator and a norepinephrine-serotonin uptake inhibitor for the treatment of obesity.A classification study of human β₃-adrenergic receptor agonists using BCUT descriptors.Sizing up pharmacotherapy for obesityComparative 3D QSAR study on β(1)-, β(2)-, and β(3)-adrenoceptor agonistsAnti-obesity and metabolic efficacy of the β3-adrenergic agonist, CL316243, in mice at thermoneutrality compared to 22°CRhein Reduces Fat Weight in db/db Mouse and Prevents Diet-Induced Obesity in C57Bl/6 Mouse through the Inhibition of PPARγ Signaling.β3 Adrenergic Stimulation Restores Nitric Oxide/Redox Balance and Enhances Endothelial Function in Hyperglycemia.β(3)-Adrenoceptor ligand development history through patent review.Differential Metabolic Effects of Beta-Blockers: an Updated Systematic Review of Nebivolol.Antagonists of GPR35 display high species ortholog selectivity and varying modes of action.Difference in intracellular temperature rise between matured and precursor brown adipocytes in response to uncoupler and β-adrenergic agonist stimuli.Folic acid supplementation modifies beta-adrenoceptor-mediated in vitro lipolysis of obese/diabetic (+db/+db) mice.The tertiary amine nitrogen atom of piperazine sulfonamides as a novel determinant of potent and selective beta3-adrenoceptor agonists.Beta 3-adrenergic receptors regulate retinal endothelial cell migration and proliferation.Metabolism and disposition of a beta 3-adrenergic receptor agonist LY 368842 in male Fisher 344 rats.Obesity Drug Update: The Lost Decade?Influence of Pilocarpine and Timolol on Human Meibomian Gland Epithelial Cells.
P2860
Q24803101-D247D5F5-4181-4EEA-B07B-1ED04EF4BA1EQ26797153-AB2FA54F-26B7-4AAD-88C1-06815956299CQ33598749-FCE5B0EB-4267-4B6B-9F0D-4B89F9A0E19DQ33917012-C7F86C72-4B66-4D09-B9F6-42609764F17CQ33969368-F14FBE6E-B08F-4FE4-91ED-469FBE6F35F9Q34332971-057F33B9-6ED2-44F6-955F-CACDA93CF2BCQ35788384-E19B0CB1-872C-4AE9-9130-9CF438E1A897Q36294278-563720E9-D9E4-4376-8158-A2DCEC3B3739Q36714097-D4473AEC-CC08-4D35-A5FF-07D46C596B60Q37853580-0035C314-A372-4098-BEAF-C708D63BE04AQ38913816-81EF14C2-8DDF-410D-A14B-FACBDFD18260Q41401817-5E95AF6D-94A9-4E08-AF5B-2711313E2D9EQ42374294-EC9C0797-D449-479C-A0EE-25A9D02DE642Q42456865-9BD603E9-56B1-4F1E-B535-7EE6C79C9BC6Q43250668-58B0577B-2328-44D6-81C9-8503BF33B42CQ44387474-489846C8-37DE-437D-AE45-8275D1828EF1Q46726536-E2772DF1-C62E-4D61-8EBC-B677EEC196B9Q46972562-6B161EA8-63E5-450E-8065-C73DE8F67A8AQ54987431-3B2CF91C-67D4-4F5E-B09E-ECA475287F75
P2860
Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans.
@ast
Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans.
@en
Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans.
@nl
type
label
Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans.
@ast
Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans.
@en
Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans.
@nl
prefLabel
Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans.
@ast
Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans.
@en
Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans.
@nl
P356
P1476
Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans.
@en
P2093
de Souza CJ
P304
P356
10.2174/1381612013397339
P577
2001-09-01T00:00:00Z